Viewing StudyNCT00101920



Ignite Creation Date: 2024-05-05 @ 11:41 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00101920
Status: COMPLETED
Last Update Posted: 2010-10-15
First Post: 2005-01-18

Brief Title: ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer NSCLC
Sponsor: Amgen
Organization: Amgen

Conditions & Keywords Data

Conditions:
Name
Lung Cancer
Non-small Cell Lung Cancer
Neoplasm Metastasis
Keywords: